Mesh Bio raises US$3.5 million of Series A funding led by East Ventures, to make its digital twin technologies available at scale
Mesh Bio, a Singapore-based health deep tech startup transforming chronic disease management through predictive analytics, announced today that it has raised US$3.5 million in Series A financing led by East Ventures, a pioneering and leading sector-agnostic venture capital firm focusing on Southeast Asia. This round of investment is also participated by Elev8, Seed Capitals, and other existing shareholders.
East Ventures consistently races in the perfect storm: 2023 recap & 2024 outlook
The tech industry weathered an intense “perfect storm” of crises these past two years. The global economy is in a complex state characterized by uncertainty, making caution our guiding principle. We find ourselves in a landscape where valuations are far from their peak, the global economy remains sluggish, inflationary pressures persist, and the threat of a potential global recession looms large.
East Ventures’ sustainability action: planted 1,250 mangroves in Central Java, Indonesia
East Ventures, a pioneering and leading venture capital firm in Indonesia and Southeast Asia, announced its latest environmental initiative: Planting 1,250 mangrove trees in the coastal regions of Central Java, located exactly at Semarang Mangrove Center, Semarang.
Compawnion, a pet health and nutrition company, secured new funding led by East Ventures
Compawnion, an Indonesian pet food company, has secured a new funding led by East Ventures, the leading and pioneering sector-agnostic venture capital firm in Indonesia and Southeast Asia. The fund will be allocated to accelerate their distribution, research and development initiatives, broaden the company’s product portfolio, and effectively reach a larger demographic of pet owners who are looking for more health-conscious and sustainable choices for their beloved companions.
Moosa Genetics, an animal genomics and biotechnology startup, announced a new funding led by East Ventures
Moosa Genetics, an animal genomics and biotechnology startup based in Indonesia, announced that the company raised funding led by East Ventures, a pioneering and leading sector-agnostic venture capital firm focusing on Southeast Asia, with the participation from angel investors. This funding will be allocated to build laboratory, team, marketing, and wagyu partnership to fulfill the demand for its customers.
East Ventures and NalaGenetics’ commitment to supporting genomic sample analysis at the Biomedical and Genome Science Initiative (BGSi)
East Ventures, a pioneering and leading venture capital (VC) firm in Indonesia and Southeast Asia, has signed a Memorandum of Understanding (MoU) with NalaGenetics, a biotechnology company focused on personalized medicine, diet, and screening. This partnership is aimed to support genomic sample analysis in Indonesia's Biomedical and Genome Science Initiative (BGSi). The ceremonial signing of this MoU took place at the East Ventures booth during the Tech in Asia Conference 2023 and was attended by Budi Gunadi Sadikin, Minister of Health of the Republic of Indonesia.
East Ventures announced its first Healthcare fund of US$30 million
East Ventures, a pioneering and leading venture capital firm in Indonesia and Southeast Asia, today announced the firm’s first healthcare-focused fund with the amount of US$30 million, which is dedicated to supporting innovative healthcare solutions in Indonesia.
AMODA, an Indonesia-based property and construction technology startup, raised Seed funding co-led by East Ventures and Living Lab Ventures
AMODA, a property and construction technology startup in Indonesia, has secured seed funding co-led by East Ventures and Living Lab Ventures. This round of investment strengthens AMODA’s balance sheet, following the pre-seed funding in 2022. This funding will be mainly allocated to expanding its product, technology, and operation capabilities.